Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, PR China.
School of Public Health, Qingdao University, 38 Dengzhou Road, Qingdao, 266021, PR China.
Eur J Med Chem. 2019 Sep 15;178:446-457. doi: 10.1016/j.ejmech.2019.06.016. Epub 2019 Jun 6.
Motivated by our interest in hydrogen sulfide bio-chemistry and ent-kaurane diterpenoid chemistry, 14 hydrogen sulfide donating derivatives (9, 11a-c, 12a-c, 13, 14, 16a-c and 17a-b) of ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane were designed and synthesized. Four human cancer cell lines (K562, Bel-7402, SGC-7901 and A549) and two normal cell lines (L-02 and PBMC) were selected for antiproliferative assay. Most derivatives showed more potent activities than the lead ent-kaurane oridonin. Among them, compound 12b exhibited the most potent antiproliferative activities, with IC values of 1.01, 0.88, 4.36 and 5.21 μM against above human cancer cell lines, respectively. Further apoptosis-related mechanism study indicated that 12b could arrest Bel-7402 cell cycle at G1 phase and induce apoptosis through mitochondria related pathway. Through Western blot assay, 12b was shown to influence the intrinsic pathway by increasing the expression of Bax, cleaved caspase-3, cytochrome c and cleaved PARP, meanwhile suppressing procaspase-3, Bcl-2, Bcl-xL and PARP.
受硫化氢生物化学和贝壳杉烷二萜化学的启发,我们设计并合成了 14 种贝壳杉烷和螺内酯型 6,7-去甲贝壳杉烷的硫化氢供体衍生物(9、11a-c、12a-c、13、14、16a-c 和 17a-b)。选择了四种人癌细胞系(K562、Bel-7402、SGC-7901 和 A549)和两种正常细胞系(L-02 和 PBMC)进行抗增殖测定。大多数衍生物显示出比先导化合物贝壳杉烷冬凌草甲素更强的活性。其中,化合物 12b 对上述人癌细胞系的增殖活性最强,IC 值分别为 1.01、0.88、4.36 和 5.21μM。进一步的凋亡相关机制研究表明,12b 可以通过线粒体相关途径将 Bel-7402 细胞周期阻滞在 G1 期并诱导细胞凋亡。通过 Western blot 检测,12b 通过增加 Bax、cleaved caspase-3、细胞色素 c 和 cleaved PARP 的表达,同时抑制 procaspase-3、Bcl-2、Bcl-xL 和 PARP 的表达,影响内在途径。